50 views | 4 days ago
Though biomarker testing is now considered standard of care for therapeutic decision making in cancer care, real-world evidence has identified several practice gaps, resulting in many patients not receiving...
46 views | 4 days ago
Nikoletta Sidiropoulos, MD describes how insourcing next generation sequencing (NGS) improved patient care at her Institution. Nikoletta Sidiropoulos is an associate professor at the Department of Pathology...
37 views | 4 days ago
Nikoletta Sidiropoulos, MD describes the importance of institutional support to ensure equitable access to biomarker testing to improve cancer patient care. Nikoletta Sidiropoulos is an associate professor...
69 views | 1 week ago
Caterina Marchiò, MD, PhD, spiega perché l'implementazione del test CGP (Comprehensive Genomic Profiling) nel proprio istituto, rispetto all'invio dei campioni a un servizio esterno, può offrire maggiori...
37 views | 1 week ago
Nicole Pfarr, Dipl.-Biol, discusses how tumor whole exome sequencing (WES) can provide valuable insights into mechanisms that drive tumor proliferation, survival, and response to therapy. WES has the...
51 views | 1 week ago
Nicole Pfarr, Dipl.-Biol, discusses how an in-house comprehensive genomic profiling (CGP) including HRD provides fast turnaround to guide patient treatment and improves laboratory operational efficiency....
30 views | 1 week ago
Enrique de Álava, MD, PhD explica los beneficios que aporta utilizar la secuenciación masiva (Next-Generation Sequencing) y oncología de precisión para los pacientes con carcinoma de pulmón. El Dr....
81 views | 1 week ago
Enrique de Álava, MD, PhD discusses the benefits of using NGS panels vs single-gene testing to guide treatment of non-small cell lung cancer patients (NSCLC) and explains the value of comprehensive...